Articles tagged with: Impact of Trump presidency on health care

Appropriations committees in U.S. Congress vote to maintain funding for Global Fund and PEPFAR

published: October, 05, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, General Health, Current Affairs, Mental Health, Research, Sexual Health, Health, Treatment, Media, Revolving Door, Guest Authors

President Trump had proposed cuts to both. From Aidspan, David Garmaise reports.

Appropriations committees in U.S. Congress vote to maintain funding for Global Fund and PEPFAR

To read the complete article by David Garmaise, visit Aidspan, here. The appropriations committees in the U.S. Senate and House of Representatives have approved funding for global health programs for the fiscal year 2018 at about the same levels as the previous year. In so doing, the committees ignored the budget proposed by President Donald Trump which called for cuts of $2.5 billion overall, including $225 million less for the Global Fund and $1 billion less for PEPFAR. The U.S. 2018

Trump government and Big Pharma threaten access to HIV medications with new NAFTA deal.

published: September, 11, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , African, Caribbean and Black, Activism, Gay Men, Youth, General Health, Treatment Guidelines -including when to start, Current Affairs, Newly Diagnosed, Upcoming Events, Research, Women, Health, International , Treatment, Media, Revolving Door, Guest Authors

If you live in North America, tell your representative: Commit to vote no on NAFTA corporate power grab!

Trump government and Big Pharma threaten access to HIV medications with new NAFTA deal.

September 8, 2017 The re-negotiation of the North American Free Trade Agreement (NAFTA) is now underway. As these critical discussions continue, the Government of Canada needs to counter the attempts by the Trump administration to ratchet up further the restrictive rules on intellectual property that create even more monopoly profits for Big Pharma at the expense of people who need affordable medicines. The Ottawa Citizen recently published our analysis and recommendations to the federal g